JESSICA TRIPP: Open Payments
NPI 1154052330 · MARQUETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 13 payments from 8 companies in 2025. Trend: 2023 $383 · 2024 $431 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $73 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Sage Therapeutics, LLC | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: Auvelity, ZURZUVAE, KRYSTEXXA, INJECTAFER, OTEZLA, VAXELIS, Ozempic, REXULTI.
Industry payments across MI — which companies pay providers there.
